Valentina Zanuso

9PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsSolid tumoursChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 09, 2023
Safety and Efficacy of Atezolizumab and Bevacizumab Combination as a First Line Treatment of Advanced Hepatocellular Carcinoma.

Valentina Zanuso, Angelo Pirozzi, Rita Balsano

|Sep 11, 2023
The rapidly evolving landscape of HCC: Selecting the optimal systemic therapy.

Valentina Zanuso, Lorenza Rimassa, Chiara Braconi

|Oct 27, 2022
Determinants of Treatment Benefit and Post-Treatment Survival for Patients with Hepatocellular Carcinoma Enrolled in Second-Line Trials after the Failure of Sorafenib Treatment.

Nicola Personeni, Tiziana Pressiani, Valentina Zanuso

|Sep 21, 2022
Assessment and Monitoring of Response to Systemic Treatment in Advanced Hepatocellular Carcinoma: Current Insights.

Antonella Cammarota, Valentina Zanuso, Tiziana Pressiani

|Sep 01, 2022
Current options and future directions of systemic therapy for advanced biliary tract cancer.

Maria Giuseppina Prete, Antonella Cammarota, Antonio D'Alessio

|Feb 14, 2022
The dual checkpoint blockade in unresectable hepatocellular carcinoma: opportunities emerging in clinical trials.

Antonella Cammarota, Valentina Zanuso, Antonio D'Alessio

Pageof 2

Frequent Collaborators

9 joint publications

Lorenza Rimassa

5 joint publications

Antonio D'Alessio

5 joint publications

Antonella Cammarota

5 joint publications

Tiziana Pressiani